| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
University of Texas Health Science Center, Department of Medicine, Oncology, 7703 Floyd Curl Drive, San Antonio, Texas 78284-7884
3 To whom correspondence should be addressed, at Department of Medicine/Oncology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284-7884.
An emerging body of evidence suggests that the heat shock proteins (hsp) may be involved in drug resistance. When hsp are induced by elevated temperatures, resistance to doxorubicin (Dox), but not to other commonly used chemotherapeutic agents, is induced in breast cancer cells. To evaluate the role of hsp27 in this phenomenon, we have transfected MDA-MB-231 breast cancer cells, which normally express low levels of hsp27, with a full-length hsp27 construct. These hsp27-overexpressing cells now display a 3-fold elevated resistance to Dox. Anchorage-dependent proliferation and anchorage-independent growth were also increased 2-4-fold in these transfectants. We have also derived a MCF-7 breast cancer cell line with amplified endogenous hsp27 which is highly resistant to Dox. When these cells are transfected with an antisense hsp27 construct, they are rendered sensitive to Dox (3-fold) with anchorage-dependent as well as anchorage-independent growth, similarly decreased. These results suggest that hsp27 specifically confers Dox resistance in human breast cancer cells and, furthermore, that hsp27 may be involved in the regulation of cell growth.
1 This work was supported by NIH Grant CA11378, a Cancer Center support grant from the National Cancer Institute CA 54174, and NIH Grant CA58183-01.
2 S. O. is a recipient of a postdoctoral fellowship from Deutscher Akademischer Austauschdienst and from the Susan G. Komen Foundation.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 6/ 7/93. Accepted 8/18/93.
This article has been cited by other articles:
![]() |
A. Havasi, Z. Li, Z. Wang, J. L. Martin, V. Botla, K. Ruchalski, J. H. Schwartz, and S. C. Borkan Hsp27 Inhibits Bax Activation and Apoptosis via a Phosphatidylinositol 3-Kinase-dependent Mechanism J. Biol. Chem., May 2, 2008; 283(18): 12305 - 12313. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. O'Callaghan-Sunol, V. L. Gabai, and M. Y. Sherman Hsp27 Modulates p53 Signaling and Suppresses Cellular Senescence Cancer Res., December 15, 2007; 67(24): 11779 - 11788. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-H. Kim, H.-J. Lee, D.-H. Lee, S. Bae, J.-W. Soh, D. Jeoung, J. Kim, C.-K. Cho, Y.-J. Lee, and Y.-S. Lee Inhibition of Heat Shock Protein 27-Mediated Resistance to DNA Damaging Agents by a Novel PKC{delta}-V5 Heptapeptide Cancer Res., July 1, 2007; 67(13): 6333 - 6341. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parcellier, M. Brunet, E. Schmitt, E. Col, C. Didelot, A. Hammann, K. Nakayama, K. I. Nakayama, S. Khochbin, E. Solary, et al. HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells FASEB J, June 1, 2006; 20(8): 1179 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cao, N. Dronadula, F. Rizvi, Q. Li, K. Srivastava, W. T. Gerthoffer, and G. N. Rao Novel Role for STAT-5B in the Regulation of Hsp27-FGF-2 Axis Facilitating Thrombin-Induced Vascular Smooth Muscle Cell Growth and Motility Circ. Res., April 14, 2006; 98(7): 913 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, H. Liu, B. Han, and J.-T. Zhang Identification of 14-3-3{sigma} as a Contributor to Drug Resistance in Human Breast Cancer Cells Using Functional Proteomic Analysis. Cancer Res., March 15, 2006; 66(6): 3248 - 3255. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Shin, M.-Y. Lee, D.-S. Shin, S. Lee, K.-H. Son, S. Koh, Y.-K. Paik, B.-M. Kwon, and D. C. Han Blocking Tumor Cell Migration and Invasion with Biphenyl Isoxazole Derivative KRIBB3, a Synthetic Molecule That Inhibits Hsp27 Phosphorylation J. Biol. Chem., December 16, 2005; 280(50): 41439 - 41448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Lee, D. Ndisang, C. Patel, J. H. Dennis, D. J. Faulkes, C. D'Arrigo, L. Samady, S. Farooqui-Kabir, R. J. Heads, D. S. Latchman, et al. Expression of the Brn-3b Transcription Factor Correlates with Expression of HSP-27 in Breast Cancer Biopsies and Is Required for Maximal Activation of the HSP-27 Promoter Cancer Res., April 15, 2005; 65(8): 3072 - 3080. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Skvortsov, B. Sarg, J. Loeffler-Ragg, I. Skvortsova, H. Lindner, H. Werner Ott, P. Lukas, K. Illmensee, and H. Zwierzina Different proteome pattern of epidermal growth factor receptor-positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment Mol. Cancer Ther., December 1, 2004; 3(12): 1551 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rocchi, A. So, S. Kojima, M. Signaevsky, E. Beraldi, L. Fazli, A. Hurtado-coll, K. Yamanaka, and M. Gleave Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer Cancer Res., September 15, 2004; 64(18): 6595 - 6602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Townson, K. M. Dobrzycka, A. V. Lee, M. Air, W. Deng, K. Kang, S. Jiang, N. Kioka, K. Michaelis, and S. Oesterreich SAFB2, a New Scaffold Attachment Factor Homolog and Estrogen Receptor Corepressor J. Biol. Chem., May 23, 2003; 278(22): 20059 - 20068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Townson, T. Sullivan, Q. Zhang, G. M. Clark, C. K. Osborne, A. V. Lee, and S. Oesterreich HET/SAF-B Overexpression Causes Growth Arrest and Multinuclearity and Is Associated with Aneuploidy in Human Breast Cancer Clin. Cancer Res., September 1, 2000; 6(9): 3788 - 3796. [Abstract] [Full Text] |
||||
![]() |
A. T. Hoang, J. Huang, N. Rudra-Ganguly, J. Zheng, W. C. Powell, S. K. Rabindran, C. Wu, and P. Roy-Burman A Novel Association between the Human Heat Shock Transcription Factor 1 (HSF1) and Prostate Adenocarcinoma Am. J. Pathol., March 1, 2000; 156(3): 857 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. GARRIDO, J.-M. BRUEY, A. FROMENTIN, A. HAMMANN, A. P. ARRIGO, and E. SOLARY HSP27 inhibits cytochrome c-dependent activation of procaspase-9 FASEB J, November 1, 1999; 13(14): 2061 - 2070. [Abstract] [Full Text] |
||||
![]() |
L. Bubendorf, M. Kolmer, J. Kononen, P. Koivisto, S. Mousses, Y. Chen, E. Mahlamaki, P. Schraml, H. Moch, N. Willi, et al. Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays J Natl Cancer Inst, October 20, 1999; 91(20): 1758 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Piotrowicz, E. Hickey, and E. G. Levin Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration FASEB J, November 1, 1998; 12(14): 1481 - 1490. [Abstract] [Full Text] |
||||
![]() |
J. K. Yun, T. S. McCormick, C. Villabona, R. R. Judware, M. B. Espinosa, and E. G. Lapetina Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia PNAS, December 9, 1997; 94(25): 13903 - 13908. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Razandi, A. Pedram, and E. R. Levin Estrogen Signals to the Preservation of Endothelial Cell Form and Function J. Biol. Chem., December 1, 2000; 275(49): 38540 - 38546. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jiang and S. Altman Protein-protein interactions with subunits of human nuclear RNase P PNAS, January 30, 2001; 98(3): 920 - 925. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |